UGent, VUB, UAntwerpen, UHasselt, ULiège, VITO and Imec are all among the partners of Qbic, which has raised $54m for its third fund.

NGT HealthCare II Impact Fund has raised a $92m fund with T3 and Hadassit joining as strategic partners.

Having found itself fighting a resolution from Crystal Amber to remove chairman Harry Rein, Allied Minds is exploring its options for the future.

Texas Medical Center has committed another $50m to its TMC Venture Fund, to be deployed over the next decade, adding to its original commitment of $25m in 2017.

Tokyo University of Science Investment Management is among the limited partners of Fiducia Growth Tech Fund, which has now achieved a first close of $28.3m.

Axelys and Investissement Québec will collaborate to deliver a new commercialisation fund called Eurêka.

Newton Biocapital’s first fund was instrumental in establishing four spinouts and it has raised $57m towards its $172m goal for its second vehicle.

University of Tokyo’s venture arm has reached a final close for its second fund thanks to commitments from 11 institutional investors including the institution itself.

Orange Grove Bio has partnered SV Investment to jointly source therapeutics in South Korea and the US and create spinouts.

Milo Werner has joined The Engine as general partner as the MIT-founded venture firm confirmed its second fund has reached $302m.